Even though CerS2 was not upregulated in our NASH models (Fig. 4B), Cer C24 was significantly augmented in the MCD group and Cer C22 was elevated in ATH mice (Fig. 4C). The gene discussed is CBLN1; the disease is metabolic dysfunction-associated steatohepatitis.